181 related articles for article (PubMed ID: 37887278)
41. Porcine induced pluripotent stem cell-derived osteoblast-like cells prevent glucocorticoid-induced bone loss in Lanyu pigs.
Liao YJ; Tang PC; Chen YH; Chu FH; Kang TC; Chen LR; Yang JR
PLoS One; 2018; 13(8):e0202155. PubMed ID: 30157199
[TBL] [Abstract][Full Text] [Related]
42. Treatment with synthetic glucocorticoid impairs bone metabolism, as revealed by in vivo imaging of osteoblasts and osteoclasts in medaka fish.
Azetsu Y; Chatani M; Dodo Y; Karakawa A; Sakai N; Negishi-Koga T; Takami M
Biomed Pharmacother; 2019 Oct; 118():109101. PubMed ID: 31315073
[TBL] [Abstract][Full Text] [Related]
43. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
44. Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss.
Wang FS; Ko JY; Yeh DW; Ke HC; Wu HL
Endocrinology; 2008 Apr; 149(4):1793-801. PubMed ID: 18174290
[TBL] [Abstract][Full Text] [Related]
45. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
46. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.
Weinstein RS; Jilka RL; Almeida M; Roberson PK; Manolagas SC
Endocrinology; 2010 Jun; 151(6):2641-9. PubMed ID: 20410195
[TBL] [Abstract][Full Text] [Related]
47. The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor.
Han L; Wang B; Wang R; Gong S; Chen G; Xu W
Stem Cell Res Ther; 2019 Dec; 10(1):377. PubMed ID: 31805987
[TBL] [Abstract][Full Text] [Related]
48. Activation of dopamine receptor D1 promotes osteogenic differentiation and reduces glucocorticoid-induced bone loss by upregulating the ERK1/2 signaling pathway.
Zhu J; Feng C; Zhang W; Wang Z; Zhong M; Tang W; Wang Z; Shi H; Yin Z; Shi J; Huang Y; Xiao L; Geng D; Wang Z
Mol Med; 2022 Feb; 28(1):23. PubMed ID: 35189819
[TBL] [Abstract][Full Text] [Related]
49. The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing's syndrome and may play a role in glucocorticoid-induced osteoporosis.
Lekva T; Bollerslev J; Kristo C; Olstad OK; Ueland T; Jemtland R
J Clin Endocrinol Metab; 2010 Jan; 95(1):246-55. PubMed ID: 19875485
[TBL] [Abstract][Full Text] [Related]
50. Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes.
Gado M; Baschant U; Hofbauer LC; Henneicke H
Front Endocrinol (Lausanne); 2022; 13():835720. PubMed ID: 35432217
[TBL] [Abstract][Full Text] [Related]
51. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes.
Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB
J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073
[TBL] [Abstract][Full Text] [Related]
52. [Glucocorticoid and Bone. The effect of glucocorticoid and PTH in osteoblast apoptosis and differentiation via interleukin 11 expression].
Endo I
Clin Calcium; 2014 Sep; 24(9):1321-8. PubMed ID: 25177004
[TBL] [Abstract][Full Text] [Related]
53. Glucocorticoid receptor-mediated
Pico MJ; Hashemi S; Xu F; Nguyen KH; Donnelly R; Moran E; Flowers S
Bone Rep; 2016 Dec; 5():222-227. PubMed ID: 28580390
[TBL] [Abstract][Full Text] [Related]
54. Beta-Ecdysone Protects Mouse Osteoblasts from Glucocorticoid-Induced Apoptosis In Vitro.
Dai WW; Wang LB; Jin GQ; Wu HJ; Zhang J; Wang CL; Wei YJ; Lee JH; Lay YE; Yao W
Planta Med; 2017 Jul; 83(11):888-894. PubMed ID: 28388784
[TBL] [Abstract][Full Text] [Related]
55. Strontium gluconate potently promotes osteoblast development and restores bone formation in glucocorticoid-induced osteoporosis rats.
Dai L; Chen X; Xiong Y; Chen J; Li J; Li D; Zhou G; Zou Y; Liu T
Biochem Biophys Res Commun; 2021 May; 554():33-40. PubMed ID: 33774277
[TBL] [Abstract][Full Text] [Related]
56. The multiple facets of glucocorticoid action in rheumatoid arthritis.
Baschant U; Lane NE; Tuckermann J
Nat Rev Rheumatol; 2012 Nov; 8(11):645-55. PubMed ID: 23045254
[TBL] [Abstract][Full Text] [Related]
57. Inhibitory effect of glucocorticoid for osteoblast apoptosis induced by activated peripheral blood mononuclear cells.
Nakashima T; Sasaki H; Tsuboi M; Kawakami A; Fujiyama K; Kiriyama T; Eguchi K; Ichikawa M; Nagataki S
Endocrinology; 1998 Apr; 139(4):2032-40. PubMed ID: 9528991
[TBL] [Abstract][Full Text] [Related]
58. Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis.
Sui B; Hu C; Zhang X; Zhao P; He T; Zhou C; Qiu X; Chen N; Zhao X; Jin Y
Stem Cells Transl Med; 2016 Sep; 5(9):1238-46. PubMed ID: 27365487
[TBL] [Abstract][Full Text] [Related]
59. Calcium tracer kinetics show decreased irreversible flow to bone in glucocorticoid treated patients.
Goans RE; Weiss GH; Abrams SA; Perez MD; Yergey AL
Calcif Tissue Int; 1995 Jun; 56(6):533-5. PubMed ID: 7648481
[TBL] [Abstract][Full Text] [Related]
60. Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis.
Boling EP
Clin Ther; 2004 Jan; 26(1):1-14. PubMed ID: 14996513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
